Total Funding
41
Total FundingVenture - Series Unknown raised
Growth Score
pts
Heat Score
-2 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
69841
Farapulse commercializing an innovative collection of catheter-based tools used to treat atrial fibrillation.
Acquired by 
Boston Scientific
- Allan Zingeler: CEOPast Role: CryoCath Technologies, VP Global Marketing & Business Development
About the Company
Farapulse commercialize an innovative collection of catheter-based tools used to treat atrial fibrillation. Farapulse are working to make atrial fibrillation ablation safer, faster, more accessible, and less expensive for millions of people.
